research and markets: early stage drug discvry

Hi all

Seems like Patrys have been mentioned in this report but you have to pay to read it. I thought I would post in case there was a slight chance someone was a member.


Here is the site and scope of report.
http://www.researchandmarkets.com/research/aff93c/early_stage_drug_discovery_in_disease_segments



The scope of this report includes:

* Coverage of pipeline molecules in various discovery and pre-clinical phases of drug development along with pipeline analysis of the leading therapeutic segments, including Oncology, CNS disorders, immunological disorders, infection, metabolic disorders and cardiovascular disorders.
* Analysis of the above mentioned disorders market in the leading geographies of the world, which are the US, the UK, Germany, France, Italy, Spain and Japan.
* Key drivers and barriers that have a significant impact on the market.
* Competitive benchmarking of leading companies. The key companies studied in this report are Hanall Pharmaceutical Co. Ltd, Patrys Limited, F. Hoffmann-La Roche Ltd, Mirna Therapeutics, Inc. and Aphios Corporation.
* Key M&A activities and licensing agreements that have taken place between 2005 and 2010 in the global Oncology, CNS disorders, immunological disorders, infection, metabolic disorders and cardiovascular disorders markets.